CVS Health Co. (NYSE:CVS) Position Boosted by DCM Advisors LLC

DCM Advisors LLC grew its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 15.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 81,530 shares of the pharmacy operator's stock after acquiring an additional 10,920 shares during the period. CVS Health comprises approximately 1.6% of DCM Advisors LLC's holdings, making the stock its 21st largest position. DCM Advisors LLC's holdings in CVS Health were worth $3,435,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of CVS. McIlrath & Eck LLC boosted its holdings in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the period. Coppell Advisory Solutions LLC lifted its holdings in CVS Health by 17.3% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock worth $56,000 after purchasing an additional 189 shares in the last quarter. EagleClaw Capital Managment LLC lifted its holdings in CVS Health by 3.4% in the 4th quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock worth $275,000 after purchasing an additional 200 shares in the last quarter. Manchester Capital Management LLC lifted its holdings in CVS Health by 4.8% in the 4th quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator's stock worth $200,000 after purchasing an additional 204 shares in the last quarter. Finally, Angeles Investment Advisors LLC lifted its stake in CVS Health by 3.7% in the 4th quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator's stock worth $256,000 after purchasing an additional 204 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Trading Up 1.0%

NYSE CVS traded up $0.59 during mid-day trading on Tuesday, hitting $61.42. The company's stock had a trading volume of 2,470,347 shares, compared to its average volume of 11,294,690. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $72.51. The stock's fifty day simple moving average is $66.01 and its two-hundred day simple moving average is $59.45. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The firm has a market capitalization of $77.69 billion, a P/E ratio of 16.77, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.31 earnings per share. Research analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were given a $0.665 dividend. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.33%. CVS Health's dividend payout ratio is presently 63.48%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several recent research reports. Evercore ISI upped their price objective on CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a report on Monday, January 27th. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Argus set a $77.00 target price on shares of CVS Health in a research report on Tuesday, February 18th. Edward Jones upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. Finally, Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $74.94.

Insider Activity at CVS Health

In related news, SVP James David Clark sold 7,513 shares of the stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares in the company, valued at $556,941.90. This represents a 47.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 1.22% of the stock is currently owned by insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.